| Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC) (NCT00002043) | Jacobus Pharmaceutical | |
| A Phase I Pharmacokinetic and Tolerance Study of 28-Day Regimens of Oral Ganciclovir (NCT00000668) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection (NCT00000823) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Collection of Blood Samples From SMART Study Participants for Future Genetic Studies (NCT00377169) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS (NCT00002330) | Roche Global Development | |
| A Study of Nystatin in the Prevention of Fungal Infections of the Mouth in Patients With AIDS or AIDS-Related Syndromes (NCT00002293) | Bristol-Myers Squibb | |
| Safety and Acceptability of PRO 2000 Vaginal Gel in HIV Uninfected Women in India (NCT00081640) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir (NCT00000697) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Epicutaneous 1-Chloro-2, 4-Dinitrobenzene (DNCB) Patch in HIV Infection. (NCT00002175) | The Honolulu Medical Group | |
| A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS (NCT00001058) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. (NCT00000641) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy (NCT00008866) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa (NCT00498056) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition (NCT00002300) | Bristol-Myers Squibb | |
| The Safety and Effectiveness of Fozivudine Tidoxil in HIV-1 Infected Patients (NCT00002385) | Anderson Clinical Research | |
| The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia (NCT00002276) | University of Pittsburgh | |
| The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the Disease (NCT00002324) | Boehringer Ingelheim | |
| Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents (NCT00011479) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone (NCT00000870) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in HIV-Infected Pregnant Women and Their Children (NCT00001106) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of and Immune Response to an HIV DNA Plasmid Vaccine Followed by HIV Adenoviral Vector Vaccine in Healthy African Adults (NCT00415649) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected Patients (NCT00002168) | Bristol-Myers Squibb | |
| A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (NCT00001003) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of How Indinavir (an Anti-HIV Drug) and Rifabutin (a Drug Used to Treat MAC, an HIV-Associated Disease) Interact in HIV-Positive and HIV-Negative Adults (NCT00000877) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of AS-101 in Patients With AIDS or AIDS Related Complex (ARC) (NCT00001006) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Study of Allogeneic Lymphocyte Transfer in HIV Infection (NCT00000852) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Drug Interactions Between Lopinavir/Ritonavir and Oral or Patch Contraceptives in HIV Infected Women (NCT00125983) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome (NCT00000726) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Study of Oral Clindamycin and Pyrimethamine for the Treatment of Toxoplasmic Encephalitis in Patients With AIDS (NCT00000674) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome (NCT00002019) | Liposome | |
| A Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of 100 mcg of Env 2-3 in MF59 (NCT00000632) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent (NCT00002091) | Community Research Initiative of New England | |
| A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons (NCT00001060) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine (NCT00002263) | Sandoz | |
| A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV Treatment (NCT00002243) | Sarawak MediChem Pharmaceuticals | |
| Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children (NCT00006325) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of the Safety and Effectiveness of Different Doses of 1592U89 in HIV-Infected Patients (NCT00002390) | Glaxo Wellcome | |
| Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) (NCT00002027) | Janssen, LP | |
| A Study of MKC-442 in Combination With Other Anti-HIV Drugs (NCT00002412) | Triangle Pharmaceuticals | |
| A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole (NCT00001065) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of HIV Levels During Pregnancy and After Childbirth (NCT00041964) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety of and Immune Response to a DNA HIV Vaccine (VRC-HIVDNA009-00-VP) in HIV Infected Individuals With Acute HIV Infection (NCT00125099) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients (NCT00006617) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Ganciclovir Used Alone or in Combination With Granulocyte-Macrophage Colony Stimulating Factor in the Treatment of Cytomegalovirus (CMV) of the Eye in Patients With AIDS (NCT00000989) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Interleukin-2 Plus Anti-HIV Therapy in HIV-Infected Children With Weakened Immune Systems (NCT00006066) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of a Two-Drug Combination in the Treatment of Patients With Hepatitis C Plus Advanced HIV Infections (NCT00001035) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Mycophenolate Mofetil and Abacavir Treatment in HIV Patients With Failed Anti-HIV Treatment (NCT00021489) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of 1592U89 in HIV-Infected Children (NCT00002197) | Glaxo Wellcome | |
| A Study of CI-1012 in HIV-Infected Patients (NCT00002196) | Parke-Davis | |
| Evaluating Immune Function Tests in People With HIV (NCT00067795) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients (NCT00000899) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Continuous High-Dose Intravenous Dextran Sulfate in Human Immunodeficiency Virus-Infected Individuals (NCT00000684) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Open Label Ganciclovir Therapy for Sight- or Life-Threatening Cytomegalovirus Disease in the Immunocompromised Patient (NCT00002025) | Hoffmann-La Roche | |
| A Study to Evaluate the Effects of Stopping Maintenance Therapy for Cytomegalovirus (CMV) Retinitis After Effective Anti-HIV Therapy (NCT00000905) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II, Open Label Study to Evaluate the Antiviral Potential of Combination Zidovudine and 2' 3'-Dideoxyinosine (Didanosine) in Patients With Asymptomatic HIV Disease (NCT00000656) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Have Not Had Success With Ganciclovir (NCT00002301) | Astra USA | |
| A Phase II Safety and Efficacy Study of Clarithromycin in the Treatment of Disseminated M. Avium Complex (MAC) Infections in Patients With AIDS (NCT00000644) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Dose Escalation Study of Synthetic Hypericin in HIV-Infected Patients With Less Than 300 CD4 Lymphocytes (NCT00000645) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV) (NCT00051077) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Randomized Dose/Formulation Comparison Study of SC-52151 (NCT00000806) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow Transplant (NCT00002284) | Glaxo Wellcome | |
| A Study to Evaluate the Safety and Efficacy of Azithromycin in Individual Patients With Serious Nontuberculous Mycobacterial Disease Who Are Failing or Intolerant of Other Available Therapy (NCT00002085) | Pfizer | |
| Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy (NCT00038259) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Simplified Drug Regimens for HIV Patients in ACTG 388 or Patients Who Responded to A First Potent Combination Regimen (NCT00014937) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications (NCT00001078) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia (NCT00001991) | Glaxo Wellcome | |
| The Safety of Four Different Dose Levels of Wobenzym in HIV-Positive Patients (NCT00002311) | Mucos Pharma GmbH and Co | |
| The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before (NCT00002291) | Fisons | |
| The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors (NCT00002418) | Bristol-Myers Squibb | |
| A Pilot Study of 566C80 for the Salvage Treatment of Toxoplasmic Encephalitis in Patients Infected With the Human Immunodeficiency Virus (HIV) Who Have Failed or Are Intolerant of Pyrimethamine-Sulfadiazine (NCT00001994) | Glaxo Wellcome | |
| Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients (NCT00007202) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452 (NCT00006495) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV Infection (NCT00000739) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of FIAC in the Treatment of Cytomegalovirus (CMV) in Patients With AIDS (NCT00000981) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Never Used Anti-HIV Drugs (NCT00001067) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of 1592U89 and Ethanol When Given Together to HIV-Infected Patients (NCT00002198) | Glaxo Wellcome | |
| Evaluation of Patients Who Have Not Had Success With Zidovudine (NCT00001025) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX (NCT00002340) | Glaxo Wellcome | |
| A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI) (NCT00000742) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDS (NCT00000741) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering Drugs (NCT00017758) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy (NCT00002072) | Ortho Pharmaceuticals | |
| Immunological and Viral Response to Antiretrovirals in HIV Patients With CD4 Cell Count Below 100 (NCT00385957) | Hospital Clinic of Barcelona | |
| A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection (NCT00000919) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive Individuals (NCT00000648) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients (NCT00002378) | Hoffmann-La Roche | |
| A Randomized Comparative Pharmacokinetic Study of Oral Ganciclovir After Treatment With Intravenous Ganciclovir for Cytomegalovirus Gastrointestinal Disease in AIDS Patients (NCT00000768) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection (NCT00002441) | VaxGen | |
| A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy (NCT00002071) | Ortho Pharmaceuticals | |
| An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies (NCT00002021) | Astra USA | |
| A Study of Dideoxycytidine Plus Zidovudine in the Treatment of AIDS or Advanced AIDS Related Complex (ARC) (NCT00000978) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin (NCT00000778) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS (NCT00002343) | Pharmacia | |
| Safety/Immunogenicity of Immunizations of ALVAC-DC-SC vs ALVAC-SC (NCT00026624) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines (NCT00000746) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis (NCT00002070) | Schering-Plough | |
| A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive Patients (NCT00002322) | Pharmacia and Upjohn | |
| Phase I Rising Dose Tolerability Study of SC-48334 in Patients With Acquired Immunodeficiency Syndrome (AIDS) and Advanced AIDS Related Complex (NCT00000692) | G D Searle | |
| Studies of HIV-1 Infection in Newly Infected Individuals in Southern Africa (NCT00006298) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study of Hyperimmune IVIG in Slowing Progression of Disease in HIV-Infected Children (NCT00000827) | National Institute of Allergy and Infectious Diseases (NIAID) | |